PPW
MRNA icon

Pinnacle Private Wealth’s Moderna MRNA Stock Holding History

Pinnacle Private Wealth’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$605K Sell
4,233
-306
-7% -$43.7K 0.24% 102
2022
Q1 		$782K Buy
4,539
+1,251
+38% +$211K 0.24% 95
2021
Q4 		$835K Buy
+3,288
New +$961K 0.26% 91

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pinnacle Private Wealth's MRNA Position: Q2 2022 in Review

Pinnacle Private Wealth reduced its Moderna (MRNA) stake by 6.7% in Q2 2022, selling an estimated $43.7K and leaving 4,233 shares worth $605K. The position accounts for 0.24% of the portfolio, ranked #102.

Pinnacle Private Wealth first reported a position in MRNA in Q4 2021 and has held it in 3 quarters since. The position peaked at $835K in Q4 2021. 980 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • Pinnacle Private Wealth held 4,233 shares of Moderna worth $605K as of Q2 2022.
  • Pinnacle Private Wealth sold 306 Moderna shares in Q2 2022, an estimated $43.7K.
  • Moderna made up 0.24% of Pinnacle Private Wealth's portfolio in Q2 2022, its #102 holding.
  • Pinnacle Private Wealth first reported a position in Moderna in Q4 2021 and has held it in 3 quarters since.
  • Pinnacle Private Wealth's Moderna position peaked at $835K in Q4 2021.
  • 980 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on Pinnacle Private Wealth's 13F filing for Q2 2022, filed 15 Jul 2022.